HOME >> BIOLOGY >> NEWS
Minneapolis chemist wins national award for unique separations

Edward L. Cussler of Minneapolis will be honored April 9 by the worlds largest scientific society for his remarkable methods and applications of separating molecules — from oxygen to pharmaceuticals — by using membranes. He will receive the 2002 Award in Separations Science and Technology from the American Chemical Society at its national meeting in Orlando, Fla.

In short, I separate chemical mixtures, said Cussler, a chemical engineering professor at the University of Minnesota. Sometimes its easy, but sometimes youre looking to pull out something like a drug, which might be only a few parts per billion in your original mixture.

At one point in his 35-year career, however, Cussler decided scientists werent taking enough advantage of membrane technology.

So I built an artificial gill, with the idea of humans being able to swim around like fish, he said. It may have started off as something between an intellectual challenge and a stunt, but it worked, and a certain dog named Muggins can attest to it.

Separation happens when any particular product moves from one side of the membrane to the other. So the more surface area a membrane supplies in any given volume, the faster the separation.

In the case of Muggins, the membrane came as thousands of hollow hairs through which water flowed while oxygen seeped out, was collected and then delivered to a sealed box. Inside the box was Muggins, whose scientific bent was apparently surpassed by the urge to take a nap.

The experiment worked so well that Cussler had to dismantle it. My students kept wanting to try it, but theyre too big, he said. The apparatus can only handle the oxygen demand of something the size of Muggins — who, by the way, is the family dog.

A more real-world application of the technique is in distillation, said Cussler. He estimates about a 20 percent improvement in efficiency is possible in distilling, or purifying, the building bl
'"/>

Contact: Sharon Worthy
s_worthy@acs.org
202-872-4371
American Chemical Society
4-Apr-2002


Page: 1 2

Related biology news :

1. Leading experts in field of gene therapy to meet in Minneapolis
2. Minneapolis researchers receive award for developing vegetable-based oils
3. UT Southwestern biochemist honored with NIH Directors Pioneer Award
4. NJIT chemist speaks Aug. 25 about compound derived from pine tree
5. NIH roadmap for biomedical research focus of chemists at American Chemical Society meeting
6. U of T research answers key question in biochemistry
7. Carnegie Mellon University hosts ACS-PRF summer school on green chemistry
8. Rutgers chemist uses NMR to elucidate protein-DNA interaction
9. New multidisciplinary research tops chemists meeting Aug. 22-26
10. Wisconsin chemists find a new chink in TBs armor
11. UCLA chemists develop new coating for nanoscale probes

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Minneapolis chemist wins national award for unique separations

(Date:12/17/2014)... Va. , Dec. 15, 2014 ... to make it easier to detect and prevent ... Today the agency started performing an ... capability will validate the authenticity of purchased microcircuits ... The new quality control measures will be conducted ...
(Date:12/17/2014)... , Dec. 16, 2014 Research and Markets ... addition of the "Global Chemical Sensor Market ... http://photos.prnewswire.com/prnh/20130307/600769 One ... increasing demand for medical sensors in biomedical applications. ... for quick and correct diagnosis during surgical procedures. ...
(Date:12/11/2014)... DUBLIN , Dec. 09, 2014 Research ... http://photos.prnewswire.com/prnh/20130307/600769 ( http://www.researchandmarkets.com/research/twhjll/biometrics_market ) ... Market in the APAC Region 2015-2019"  report to ... emerging in this market is advances in technology. ... to upgrade biometric solutions to the latest standard ...
Breaking Biology News(10 mins):Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 2Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 3Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
(Date:12/17/2014)... AUSTIN, Texas , Dec. 16, 2014  Vermillion, ... company focused on gynecologic disease, today announced the next ... into a premier bio-analytics solutions provider with the naming ... to President and Chief Executive Officer, while current Chairman ... will continue to serve as Chairman. These changes are ...
(Date:12/17/2014)... ROCKVILLE, Md. , Dec. 17, 2014 ... biopharmaceutical company dedicated to the acquisition, development and commercialization ... needs for the global market with a primary commercial ... that it has been granted a Type C meeting ... that the meeting will be held in February 2015.  ...
(Date:12/17/2014)... , Dec. 17, 2014   Synageva BioPharma ... company developing therapeutic products for rare disorders, announced today ... being held in San Francisco, CA. ... and Chief Executive Officer, will present on Monday, January ... The presentation will be webcast live and may be ...
(Date:12/15/2014)... & PETACH TIKVAH, Israel , Dec. ... BCLI ), a leading developer of adult stem ... subsidiary Brainstorm Cell Therapeutics Ltd. was awarded a grant ... Office of the Chief Scientist (OCS).  This is ... of grant support from the Office of the Chief ...
Breaking Biology Technology:Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 3Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 4CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 2CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 3CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 4CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 5BrainStorm Receives $1,100,000 for its 8th Annual Non-Dilutive Grant from Israel's Chief Scientist Office 2BrainStorm Receives $1,100,000 for its 8th Annual Non-Dilutive Grant from Israel's Chief Scientist Office 3
Cached News: